OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Allergy and Clinical Immunology-In Practice is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Cover 1	340
The Microbiome in Clinical Allergy and Immunology: Emerging Role as Friend and Foe	159
Dupilumab and Eosinophils: A Red Flag?	130
Asthma and Comorbid Conditions	119
CME Exam: Emerging Systemic Therapeutic Biologics and Small Molecules for Atopic Dermatitis: How to Decide Which Treatment Is Right for Your Patients	115
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia	105
Diagnosis and Management of Pollen Food Allergy Syndrome to Nuts	105
A Diagnostic Approach to Gastrointestinal Symptoms in Patients with Common Variable Immunodeficiency	100
Original Article Highlights From This Issue	99
Patient perspectives on reproductive options for hereditary angioedema: A cross-sectional survey study	99
Reply to “Peanut allergy prevention: A mother’s perspective”	86
Managing Atopic Dermatitis in Patients With Skin of Color	82
March 2023 Practice Notes	81
Cover 1	80
Digital Health for Asthma Management: Electronic Medication Monitoring for Adherence as a Case Example	77
Table of Contents	77
Table of Contents	76
Respiratory Infections in Patients with Primary Immunodeficiency	74
Reply to “Chronic rhinosinusitis and the development of non-cystic fibrosis bronchiectasis”	71
Cough-Variant Asthma: A Review of Clinical Characteristics, Diagnosis, and Pathophysiology	68
A Pharmacovigilance Analysis of Post-Marketing Safety of Tezepelumab	66
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	65
Insect Allergy: Barriers in Training and Practice—A Work Group Report of the AAAAI Anaphylaxis Committee	63
Prospective Piperacillin Lymphocyte Transformation Testing in Patients With Cystic Fibrosis Receiving Regular and Desensitization Courses of Piperacillin-Tazobactam	62
Cost-Effectiveness of Oral Immunotherapy for Egg Allergy According to Age of Therapy Commencement	61

Climate Change and Allergens: Current and Future Impacts	61
Racial and Ethnic Disparities in Allergen Immunotherapy Prescription for Allergic Rhinitis	60
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective	59
Feeding difficulties in children with food protein–induced enterocolitis syndrome	59
Is a Prolonged Drug Provocation Test Better Than a Single-Day Drug Provocation Test? A Systematic Review and Meta-Analysis	59
Peanut oral food challenges and subsequent feeding of peanuts in infants	59
Microbiome–Immune Interactions in Allergy and Asthma	57
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	57
The impact of COVID-19 on a national sample of US adults with food allergy	55
Real-world data are critical for the implementation of preschool food allergen immunotherapy	55
A Case Study in Health Disparities: Barriers to Immunotherapy for Venom-Induced Anaphylaxis	54
Seeing the Forest for the Trees: Evaluating Population Data in Allergy-Immunology	53
Addressing the Social Determinants of Health Is Critical Even in Preschool-Age Children With Recurrent Wheezing	53
Information for Readers	52
An Updated Survey of SCID Outcomes Without Preconditioning Chemotherapy	52
Editorial Board	51
Lone Ranger or Handpicked Posse? How Multidisciplinary Assessment Helps Evaluate Suspected Laryngeal Disorders	51
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	51
Information for Readers	51
Practice Notes from the AAAAI	51
Clinical features and burden of genital attacks in hereditary angioedema	50
Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study	50
High SABA Using and Poor Asthma Control: Blaming Poor Adherence or Missing the Phenotype?	49
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis	49